Augmenting Vaccine Efficacy against Delta Variant with ‘Mycobacterium-w’-Mediated Modulation of NK-ADCC and TLR-MYD88 Pathways

Mycobacterium-w (Mw) was shown to boost adaptive natural killer (ANK) cells and protect against COVID-19 during the first wave of the pandemic. As a follow-up of the trial, 50 healthcare workers (HCW) who had received Mw in September 2020 and subsequently received at least one dose of ChAdOx1 nCoV-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Jaiswal, Sarita Rani, Saifullah, Ashraf, Arunachalam, Jaganath, Lakhchaura, Rohit, Tailor, Dhanir, Mehta, Anupama, Bhagawati, Gitali, Aiyer, Hemamalini, Biswas, Subhrajit, Khamar, Bakulesh, Malhotra, Sanjay V., Chakrabarti, Suparno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966412/
https://www.ncbi.nlm.nih.gov/pubmed/36851206
http://dx.doi.org/10.3390/vaccines11020328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966412/
https://www.ncbi.nlm.nih.gov/pubmed/36851206
http://dx.doi.org/10.3390/vaccines11020328

Ejemplares similares